Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

  • This share is currently suspended. It was suspended at a price of 398.00
  • There is currently no data for TYMN

Form 8.3 - TYMAN PLC

25 Jul 2024 15:30

RNS Number : 9006X
Barclays PLC
25 July 2024
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Barclays PLC.

(b)

Owner or controller of interest and short positions disclosed, if different from 1(a):

 

(c)

Name of offeror/offeree in relation to whose relevant securities this form relates:

TYMAN PLC

(d)

If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e)

Date position held/dealing undertaken:

24 Jul 2024

(f)

In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

YES: QUANEX BUILDING PRODUCTS CORP

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing(if any)

Class of relevant security:

5p ordinary

Interests

Short Positions

Number

(%)

Number

(%)

(1) Relevant securities owned and/or controlled:

4,807,295

2.45%

220,626

0.11%

(2) Cash-settled derivatives:

102,652

0.05%

4,620,097

2.35%

(3) Stock-settled derivatives (including options) and agreements to purchase/sell: 

0

0.00%

0

0.00%

TOTAL: 

4,909,947

2.50%

4,840,723

2.47%

(b)

Rights to subscribe for new securities (including directors and other executive options)

Class of relevant security in relation to which subscription right exists

Details, including nature of the rights concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchase and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

5p ordinary

Purchase

35,000

3.9844 GBP

5p ordinary

Purchase

31,635

4.0050 GBP

5p ordinary

Purchase

17,440

4.0037 GBP

5p ordinary

Purchase

4,359

3.9998 GBP

5p ordinary

Purchase

4,097

3.9996 GBP

5p ordinary

Purchase

4,051

4.0000 GBP

5p ordinary

Purchase

805

4.0048 GBP

5p ordinary

Purchase

669

3.9834 GBP

5p ordinary

Purchase

308

3.9750 GBP

5p ordinary

Purchase

100

3.9450 GBP

5p ordinary

Sale

26,799

4.0050 GBP

5p ordinary

Sale

17,061

3.9976 GBP

5p ordinary

Sale

5,992

4.0022 GBP

5p ordinary

Sale

3,152

3.9980 GBP

5p ordinary

Sale

2,201

4.0000 GBP

5p ordinary

Sale

710

3.9850 GBP

5p ordinary

Sale

25

3.9650 GBP

(b)

Cash-settled derivative transactions

Class of relevant security

Product description

Nature of dealing

Number of reference securities

Price per unit

5p ordinary

CFD

Decreasing Short

2,692

3.9957 GBP

5p ordinary

CFD

Decreasing Short

26,799

4.0050 GBP

5p ordinary

CFD

Increasing Short

679

3.9839 GBP

5p ordinary

CFD

Increasing Short

1,904

3.9941 GBP

5p ordinary

CFD

Increasing Short

4,359

4.0001 GBP

5p ordinary

CFD

Increasing Short

25,052

4.0050 GBP

5p ordinary

SWAP

Opening Long

1,264

3.9921 GBP

5p ordinary

SWAP

Opening Short

15,536

4.0050 GBP

5p ordinary

SWAP

Decreasing Short

5,698

3.9943 GBP

5p ordinary

SWAP

Decreasing Short

3,152

3.9980 GBP

5p ordinary

SWAP

Decreasing Short

2,716

4.0050 GBP

5p ordinary

SWAP

Increasing Short

100

3.9450 GBP

5p ordinary

SWAP

Increasing Short

23

4.0050 GBP

5p ordinary

SWAP

Increasing Short

35,000

3.9844 GBP

5p ordinary

SWAP

Decreasing Short

5,721

3.9978 GBP

5p ordinary

SWAP

Decreasing Short

2,081

4.0000 GBP

5p ordinary

SWAP

Decreasing Short

2,012

4.0050 GBP

5p ordinary

SWAP

Increasing Short

308

3.9750 GBP

5p ordinary

SWAP

Increasing Short

62

4.0050 GBP

5p ordinary

SWAP

Increasing Short

4,097

3.9996 GBP

(c)

Stock-settled derivative transactions (including options)

(i)

Writing, selling, purchasing or varying

Class of relevant security

Product description

Writing, purchasing, selling, varying etc

Number of securities to which option relates

Exercise price per unit

Type

Expiry date

Option money paid/ received per unit

(ii)

Exercising

 

Class of relevant security

Product description

Exercising/ exercised against

Number of securities

Exercise price per unit

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of Dealings

Details

Price per unit (if applicable)

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights of future acquisition or disposal of any relevant securities to which any derivative is referenced:

NONE

(c)

Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

25 Jul 2024

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETQKPBBQBKDFOB
Date   Source Headline
23rd Apr 202411:53 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:45 amRNSForm 8.3 - Tyman plc
23rd Apr 202411:41 amPRNForm 8.3 - Tyman plc
23rd Apr 202411:35 amRNSForm 8.5 (EPT/RI) - Tyman Plc
23rd Apr 202411:32 amRNSForm 8.3 -Quanex Building Products Corporation
23rd Apr 202411:29 amRNSForm 8.3 - Tyman plc
23rd Apr 202410:49 amRNSForm 8.5 (EPT/RI) - Tyman Plc
22nd Apr 20242:59 pmRNSForm 8.3 - Quanex Building Products Corporation
22nd Apr 20242:57 pmRNSForm 8.3 - Tyman plc
22nd Apr 202412:01 pmPRNForm 8.3 - Tyman plc
22nd Apr 20247:00 amRNSRecommended Cash and Share Offer
17th Apr 202411:22 amRNSHolding(s) in Company
28th Mar 20247:00 amRNS2023 Annual Report & Notice of AGM
7th Mar 20247:00 amRNSFinal Results
31st Jan 20247:00 amRNSNotice of Results
10th Jan 20248:00 amRNSDirector Declaration
27th Nov 20236:17 pmRNSDirector/PDMR Shareholding
27th Nov 20237:00 amRNSAppointment of new CEO
20th Nov 20232:00 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSTrading Statement
31st Oct 20237:00 amRNSCapital Markets Event
2nd Oct 20237:00 amRNSNotice of Capital Markets Event
25th Jul 20237:00 amRNSHalf-year Report
12th Jul 20235:00 pmRNSAcquisition of Lawrence Industries
8th Jun 20239:21 amRNSHolding(s) in Company
1st Jun 20237:00 amRNSSBTi approval of carbon reduction targets
31st May 20237:00 amRNSDirectorate Changes
26th May 202310:59 amRNSDirector/PDMR Shareholding
19th May 202310:24 amRNSDirector/PDMR Shareholding
18th May 20231:30 pmRNSResult of AGM
18th May 20237:00 amRNSAGM Trading Update
21st Apr 20237:00 amRNSAppointment of Interim Chief Financial Officer
21st Apr 20237:00 amRNSDirector/PDMR Shareholding
6th Apr 20233:10 pmRNSAGM Update - Withdrawal of AGM Resolution
6th Apr 20237:00 amRNSDirectorate Change
3rd Apr 20237:00 amRNSAnnual Financial Report
30th Mar 20239:10 amRNSDirector/PDMR Shareholding
24th Mar 20231:34 pmRNSHolding(s) in Company
22nd Mar 20234:30 pmRNSDirector/PDMR Shareholding
14th Mar 20234:16 pmRNSDirector/PDMR Shareholding
3rd Mar 20235:00 pmRNSDirector/PDMR Shareholding
2nd Mar 20237:00 amRNSFinal Results
16th Feb 20237:00 amRNSNotice of Results
28th Dec 20223:53 pmRNSHolding(s) in Company
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.